NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

Caliber’s LINK Treasury Mandate Could Be A Game Changer For StoneX Group (SNEX)

Earlier this month, Caliber announced it had selected StoneX as an additional institutional platform for trading and custody to support its Digital Asset Treasury strategy centered on Chainlink’s token, LINK, using StoneX Prime’s deep liquidity and institutional-grade infrastructure. This mandate reinforces StoneX’s position as a key infrastructure provider for listed companies seeking transparent, on-balance-sheet exposure to digital assets. Next, we’ll examine how StoneX’s role in...
NYSE:GMED
NYSE:GMEDMedical Equipment

How Investors May Respond To Globus Medical (GMED) Analyst Optimism Around Clinical Trial Momentum

In recent days, Globus Medical drew renewed attention as multiple research firms reaffirmed positive views on the company, citing confidence in its musculoskeletal and enabling-technology portfolio alongside encouraging clinical trial progress. What stands out is that this cluster of upbeat analyst opinions, combined with clinical milestones, appears to be reshaping how investors assess Globus Medical’s long-term growth drivers and execution risks. Next, we’ll examine how this wave of...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

SS&C Technologies (SSNC): Valuation Check After Improved Hedge Fund Redemption Trends Signal Stronger Asset Retention

SS&C Technologies Holdings (SSNC) just reported that its GlobeOp Forward Redemption Indicator slipped to roughly 2% in December, down from the prior month and last year. This hints at steadier hedge fund assets on its platform. See our latest analysis for SS&C Technologies Holdings. That backdrop of steadier hedge fund assets comes after a busy period, including SS&C presenting at the Nasdaq Investor Conference in London. It helps explain why the stock’s roughly 16% year to date share price...
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Reassessing Grocery Outlet (GO) Valuation After Analyst Downgrades and Weaker Same-Store Sales

Grocery Outlet Holding (GO) is back in focus after a wave of cautious analyst moves, sparked by weaker November same store sales and a sharp drop in EBT driven purchases among its budget conscious shoppers. See our latest analysis for Grocery Outlet Holding. The stock’s slide has been steady rather than sudden, with a 90 day share price return of minus 35.9 percent and a one year total shareholder return of minus 40.23 percent underscoring that momentum is clearly fading as investors reassess...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Jack Henry (JKHY) Valuation Check After Analyst Upgrades, Raised 2026 Guidance and Strong Operating Momentum

Jack Henry and Associates (JKHY) has quietly turned into a momentum story, with upbeat earnings, higher 2026 guidance, and fresh client wins now backed by a wave of supportive analyst upgrades. See our latest analysis for Jack Henry & Associates. Those stronger earnings, upgraded ratings, and steady client wins have clearly reset expectations, with the share price now at $184.5 and a roughly 22% 3 month share price return signaling building momentum despite a more modest 1 year total...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Should Coca-Cola Consolidated’s US$1.35 Billion Refinancing Shift Require Action From COKE Investors?

On December 8, 2025, Coca-Cola Consolidated entered into senior unsecured term loan agreements with Wells Fargo and other lenders for US$1.35 billion in total, maturing in 2028 and 2030, to refinance a US$1.20 billion bridge loan and fund general corporate purposes. The mix of three- and five-year facilities, flexible prepayment terms and covenants tied to cash flow and leverage underscores the company’s emphasis on maintaining funding flexibility while supporting potential shareholder...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC): Revisiting Valuation After Q3 2025 Earnings Beat and Upgraded Guidance

Henry Schein (HSIC) jumped about 11% after its Q3 2025 earnings beat expectations on both adjusted EPS and revenue, and management raised full year profit guidance alongside higher anticipated sales growth. See our latest analysis for Henry Schein. That earnings pop builds on a steady uptrend, with a roughly 14% 3 month share price return and about 11% 1 year total shareholder return suggesting momentum is quietly rebuilding after a softer multi year stretch. If Henry Schein’s latest move has...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Why Broadcom (AVGO) Is Down 5.4% After Strong AI Outlook Meets Margin Concerns And What's Next

Earlier this month, Broadcom reported full-year 2025 sales of US$63.89 billion and net income of US$23.13 billion, raised its quarterly dividend by 10% to US$0.65 per share, and guided for first-quarter 2026 revenue of about US$19.10 billion, implying a 28% increase from the prior-year period. The company’s stronger earnings, higher dividend, and AI-driven backlog have coincided with sharp swings in sentiment as investors weigh rapid AI growth against management’s warning about pressure on...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Tenable (TENB) Valuation Check After New U.S. GSA OneGov Federal Cloud Security Agreement

Tenable Holdings (TENB) just locked in a OneGov agreement with the U.S. GSA, opening the door to wider adoption of its FedRAMP authorized cloud security across federal agencies, including the Department of Defense, through 2027. See our latest analysis for Tenable Holdings. Even with this federal tailwind and a new CTO sharpening its AI and exposure management strategy, Tenable’s momentum has cooled lately. The stock has delivered a roughly mid 30 percent year to date share price return and a...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Will Cirrus Logic's (CRUS) Automotive-Grade Haptics Launch Redefine Its Diversification Narrative?

In December 2025, Cirrus Logic launched its first AEC-Q100 automotive-qualified closed-loop haptic drivers, the CS40L51, CS40L52 and CS40L53, aimed at delivering high-definition tactile feedback across in-cabin interfaces such as displays, steering wheels and smart surfaces. This move extends Cirrus Logic’s haptics expertise from consumer electronics into automotive, potentially opening a new end market where consistent, premium tactile user experiences are becoming a key interior design...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

Patria Investments (PAX): Evaluating Valuation After Leadership Reshuffle and New Global COO Appointment

Patria Investments (PAX) just reshuffled key leadership, naming a new Global COO and planning a CFO transition for 2026, with these moves aimed at tightening execution as the stock rides solid recent momentum. See our latest analysis for Patria Investments. Those leadership upgrades come as Patria’s 1 month share price return of 9.81% and 37.10% share price return year to date, alongside a 43.04% 1 year total shareholder return, signal that momentum is still building rather than fading around...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Amicus Therapeutics (FOLD): Assessing Valuation After a 30% Monthly and 65% Three-Month Share Price Surge

Amicus Therapeutics (FOLD) has quietly delivered a strong run lately, with the stock climbing over 30% in the past month and roughly 65% over the past 3 months. See our latest analysis for Amicus Therapeutics. That surge sits on top of a solid backdrop, with the share price return over the past year also firmly positive. This suggests sentiment is shifting toward Amicus as its rare disease portfolio matures and execution risks feel lower. If Amicus has sparked your interest, it is worth...
NYSE:ACVA
NYSE:ACVACommercial Services

How Investors May Respond To ACV Auctions (ACVA) CEO Share Buying Amid Analyst Rating Downgrade

Recently, ACV Auctions’ CEO bought more than 31,000 company shares, even as a major financial firm shifted its rating from Buy to Hold, highlighting conflicting signals for investors. This rare combination of insider conviction and external caution throws a spotlight on ACV’s underlying business quality, cash generation challenges, and competitive position. Next, we’ll explore how the CEO’s sizable insider purchase might influence ACV Auctions’ growth-focused investment narrative and...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Is Activist Pressure After Carbon6 Forcing a Rethink of SPS Commerce’s (SPSC) Capital Allocation Discipline?

SPS Commerce, a long-time provider of cloud-based supply chain management software, has recently faced pressure after its early‑2025 Carbon6 acquisition was undermined by Amazon marketplace rule changes and activist investor Anson began pushing for a potential sale of the company. This combination of a misjudged move into the Amazon seller ecosystem and escalating activist involvement has raised fresh questions about SPS Commerce's capital allocation discipline and boardroom...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora Innovation (AUR): Valuation Check After Landmark Autonomous Proppant Hauling Deal in the Permian Basin

Aurora Innovation (AUR) just took a meaningful commercial step, partnering with Detmar Logistics to run 24/7 autonomous proppant hauls in the Permian Basin, the first frac sand runs on public roads using driverless trucks. See our latest analysis for Aurora Innovation. The deal lands at a time when sentiment on Aurora has been choppy, with a recent 10.05% 1 month share price return not enough to offset a roughly 32% year to date share price decline, and a far stronger three year total...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Assessing Golar LNG (NasdaqGS:GLNG)’s Valuation After Its Recent Share Price Rebound

Golar LNG (GLNG) has quietly outperformed the broader energy sector over the past month, gaining about 6%, even as its past 3 months and year to date returns remain negative. See our latest analysis for Golar LNG. That recent 1 month share price return of 5.54% looks more like a relief rally than a full trend change, given the weaker year to date share price performance and still solid 5 year total shareholder return of 350.46%. If Golar’s move has you watching the energy space more closely,...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Valuation Check After Fresh Buy Ratings and Higher 2026 Cloud Revenue Outlook

Atlassian (TEAM) just picked up fresh Wall Street support as new coverage highlighted its long term growth story, while the company lifted its 2026 cloud revenue outlook and reaffirmed its multi year expansion targets. See our latest analysis for Atlassian. Those upbeat growth signals are arriving after a choppy run, with Atlassian’s share price now at $161.07 and showing a 1 month share price return of 10.11 percent but a much weaker year to date share price return of negative 33.55 percent...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Is Celldex (CLDX) Using Barzolvolimab’s Phase 3 Urticaria Bet To Redefine Its Core Strategy?

In December 2025, Celldex Therapeutics began a global Phase 3 EMBARQ-ColdU and SD trial of barzolvolimab in adults with cold urticaria and symptomatic dermographism who remain symptomatic despite H1 antihistamines or biologics, enrolling about 240 patients across approximately 75 sites in 7 countries with complete response at Week 12 as the primary endpoint. This late-stage program builds directly on earlier placebo-controlled Phase 2 data showing rapid, durable clinical responses and...
NYSE:UVV
NYSE:UVVTobacco

How Investors May Respond To Universal (UVV) Expanding Its US$1.40 Billion Long-Term Credit Facility

Universal Corporation recently entered into a new bank credit agreement that took effect on December 9, 2025, establishing a US$1.40 billion senior unsecured facility comprising a five-year US$780 million revolving credit line, a funded US$275 million five-year term loan, and a funded US$345 million seven-year term loan, replacing its prior US$1.15 billion facility. This expanded mix of longer-dated term loans and a larger revolving facility increases Universal’s financial flexibility,...
NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

Advancing Privosegtor Toward PIONEER Registrational Trials Could Be A Game Changer For Oculis (OCS)

Oculis Holding AG recently advanced its neuro-ophthalmology candidate privosegtor (OCS-05) toward registrational PIONEER trials after a positive FDA meeting, while also preparing additional clinical studies for licaminlimab in dry eye disease. This progression signals an effort to build a differentiated ophthalmology pipeline spanning retinal, inflammatory, and neuroprotective conditions with potentially precision-focused therapies. We’ll now examine how advancing privosegtor into late-stage...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

How Record Volumes and First On‑Chain CD Auction Could Shape Tradeweb Markets (TW) Investors

In November 2025, Tradeweb Markets reported record total trading volume of US$56.80 trillion and average daily volume of US$2.90 trillion, alongside completing the industry’s first fully electronic on-chain auction for brokered certificates of deposit with Alphaledger’s blockchain technology. These milestones underline how Tradeweb is deepening the electronification of fixed income markets and using blockchain to streamline traditionally manual workflows in bond trading. We’ll explore how...
NYSE:HE
NYSE:HEElectric Utilities

Hawaiian Electric (HE) valuation check as S&P SmallCap 600 entry and wildfire litigation shape its outlook

Hawaiian Electric Industries (HE) is back in focus as it prepares to join the S&P SmallCap 600 on December 22, 2025, even while Maui wildfire litigation and clean energy investments shape its longer term risk profile. See our latest analysis for Hawaiian Electric Industries. The stock has been choppy lately, with a 1 day share price return of minus 6.24 percent, but a year to date share price return of 20.85 percent suggests tentative momentum as investors weigh wildfire liabilities against...
NYSE:FHN
NYSE:FHNBanks

First Horizon (FHN): Revisiting Valuation After a Quiet but Steady Share Price Rebound

First Horizon (FHN) has been quietly grinding higher, with the stock up about 2% in the past day, 4% this week, and roughly 12% over the past month as investors revisit regional banks. See our latest analysis for First Horizon. Zooming out, First Horizon’s share price has climbed steadily this year, with a strong year to date share price return and a solid one year total shareholder return suggesting momentum is quietly rebuilding as investors reassess regional bank risk and growth...
NYSE:VG
NYSE:VGOil and Gas

Is Venture Global’s Recent 73.5% Slide Creating a Long Term Opportunity?

If you are looking at Venture Global and wondering whether the recent slump has quietly turned it into a value play, you are not alone. The stock has bounced 3.3% over the last week even after a steep 12.4% drop over 30 days and a bruising 73.5% slide year to date. This combination often signals the market is rapidly reassessing both its growth prospects and risk profile. Recent headlines around Venture Global have centered on shifting investor sentiment in the LNG and broader energy space,...